- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
PFAS Exposure tied with Weaker Bones in Teen Boys: Study
PFAS Exposure is tied with Weaker Bones in Teen Boys, according to a recent study published in The Journal of Clinical Endocrinology & Metabolism.
Per- and polyfluoroalkyl substances (PFAS) and phthalates are two families of environmental endocrine disruptors that may be associated with areal lower bone mineral density (aBMD).
A study examined associations between serum PFAS and urinary phthalate biomarker concentrations and their mixtures with aBMD Z-score in adolescents.
They examined serial cross-sectional data from male (n=453) and female (n=395) 12-19 year old participants in the 2011—2016 National Health and Nutrition Examination Survey with measures of serum PFAS, urinary phthalate metabolites, and dual-energy X-ray absorptiometry aBMD Z-score (total body less head). In sex-specific models, we used linear regression to examine associations of individual PFAS and phthalate biomarkers with aBMD Z-score, and Bayesian kernel machine regression (BKMR) to examine the association of the overall PFAS/phthalate biomarker mixture with aBMD Z-score. We replicated the analysis, stratifying by race/ethnicity.
Results:
- Participants were (mean ± SD) 15 ± 2.1 years old.
- In males, each doubling of serum perfluorooctanoate (PFOA), perfluorooctane sulfonate rinary mono-isobutyl phthalate (MiBP), mono-n-butyl phthalate, and the overall PFAS/phthalate mixture was associated with a lower aBMD Z-score (e.g., for PFOA: -0.24, 95% CI, -0.41, -0.06).
- Serum PFOA and urinary MiBP were associated with higher aBMD Z-score in females (e.g., for PFOA: 0.09, 95% CI, -0.07, 0.25). Findings did not differ by race/ethnicity.
Thus, certain PFAS and phthalates may reduce bone mineral density in adolescent males. Bone mineral density tracks across the lifecourse, so if replicated in longitudinal cohorts, this finding may have implications for lifelong skeletal health.
Reference:
Serum PFAS and Urinary Phthalate Biomarker Concentrations and Bone Mineral Density in 12-19 Year Olds: 2011-2016 NHANES Get access Arrow by Jenny L Carwile et al. published in the Journal of Clinical Endocrinology & Metabolism
https://doi.org/10.1210/clinem/dgac228
Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751